Neutralizing Antibodies against SARS-CoV-2 Beta and Omicron Variants Inhibition Comparison after BNT162b2 mRNA Booster Doses with a New PETIA sVNT Assay.

Marta FogolariBruno Daniele LeoniMarina De CesarisRita ItalianoFlavio DaviniGinevra Azzurra MiccoliDaniele DonatiLuigi ClericoAndrea StanzialeGiovanni SaviniNicola Petrosillo Massimo CiccozziLorenzo SommellaElisabetta RivaPaolo FaziiSilvia Angeletti

Published in: Diagnostics (Basel, Switzerland) (2023)

This study correlates vaccine-induced IgG expression and neutralizing activity using a new PETIA assay, suggesting its usefulness for SARS-CoV2 infection management.

Keyphrases

sars cov
high throughput
respiratory syndrome coronavirus
dengue virus
poor prognosis
binding protein
diabetic rats
copy number
drug induced
oxidative stress
coronavirus disease
genome wide
clinical evaluation